Cargando…
Age is a prognostic factor affecting survival in lung cancer patients
Despite all efforts at management, prognosis of advanced lung cancer is extremely poor, with a median survival time of ~1 year. The number of cancer patients aged >70 years is significantly increased among the cancer patient population. The aim of this study was to investigate the clinical import...
Autores principales: | TAS, FARUK, CIFTCI, RUMEYSA, KILIC, LEYLA, KARABULUT, SENEM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813578/ https://www.ncbi.nlm.nih.gov/pubmed/24179550 http://dx.doi.org/10.3892/ol.2013.1566 |
Ejemplares similares
-
Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy
por: Faruk Aykan, N., et al.
Publicado: (2013) -
Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival
por: TAS, FARUK, et al.
Publicado: (2013) -
Intolerance to Sunitinib Treatment in Hemodialysis Patients With Metastatic Renal Cell Carcinoma
por: Yildiz, Ibrahim, et al.
Publicado: (2014) -
Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer
por: Afsar, Cigdem Usul, et al.
Publicado: (2018) -
Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma
por: Tas, Faruk, et al.
Publicado: (2016)